Pro- and Synbiotics to Prevent Sepsis in Major Surgery and Severe Emergencies

被引:18
作者
Bengmark, Stig [1 ,2 ]
机构
[1] Lund Univ, Dept Surg, Lund, Sweden
[2] UCL, Div Surg & Intervent Sci, London WC1E 6AU, England
关键词
probiotics; microbiota; nutrition; sepsis; pancreatitis; encephalopathy; INDUCED BACTERIAL TRANSLOCATION; MECHANICAL BOWEL PREPARATION; RANDOMIZED CLINICAL-TRIAL; EARLY ENTERAL NUTRITION; CRITICALLY-ILL PATIENTS; FERMENTED OATMEAL SOUP; MULTIPLE-ORGAN FAILURE; NF-KAPPA-B; ELEMENTAL DIET; LACTOBACILLUS-ACIDOPHILUS;
D O I
10.3390/nu4020091
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Septic morbidity associated with advanced surgical and medical treatments is unacceptably high, and so is the incidence of complications occurring in connection with acute emergencies such as severe trauma and severe acute pancreatitis. Only considering the US, it will annually affect approximately (app) 300 million (mill) of a population of almost one million inhabitants and cause the death of more than 200,000 patients, making sepsis the tenth most common cause of death in the US. Two major factors affect this, the lifestyle-associated increased weakness of the immune defense systems, but more than this the artificial environment associated with modern treatments such as mechanical ventilation, use of tubes, drains, intravascular lines, artificial nutrition and extensive use of synthetic chemical drugs, methods all known to reduce or eliminate the human microbiota and impair immune functions and increase systemic inflammation. Attempts to recondition the gut by the supply of microorganisms have sometimes shown remarkably good results, but too often failed. Many factors contribute to the lack of success: unsuitable choice of probiotic species, too low dose, but most importantly, this bio-ecological treatment has never been given the opportunity to be tried as an alternative treatment. Instead it has most often been applied as complementary to all the other treatments mentioned above, including antibiotic treatment. The supplemented lactic acid bacteria have most often been killed already before they have reached their targeted organs.
引用
收藏
页码:91 / 111
页数:21
相关论文
共 100 条
[1]
Nutrigenomics:: From molecular nutrition to prevention of disease [J].
Afman, L ;
Müller, M .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2006, 106 (04) :569-576
[2]
Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[3]
Ahrné S, 1998, J APPL MICROBIOL, V85, P88
[4]
Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial [J].
Alberda, Cathy ;
Gramlich, Leah ;
Meddings, Jon ;
Field, Catherine ;
McCargar, Linda ;
Kutsogiannis, Demetrios ;
Fedorak, Richard ;
Madsen, Karen .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03) :816-823
[5]
Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[6]
Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined [J].
Alverdy, JC ;
Laughlin, RS ;
Wu, LC .
CRITICAL CARE MEDICINE, 2003, 31 (02) :598-607
[7]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[8]
[Anonymous], 2009, NUTRIGENOMICS PROTEO, DOI DOI 10.1002/9780813807263.CH12
[9]
[Anonymous], BRIT J INTENSIVE CAR
[10]
Arias Elizabeth, 2003, Natl Vital Stat Rep, V51, P1